ALPINE IMMUNE SCIENCES, INC. Operating Lease Cost
ALPINE IMMUNE SCIENCES, INC. reported Operating Lease Cost of $1.84 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-03-20
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for the quarter ending 2019-12-31 was $654.00K, a 217.48% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for the quarter ending 2019-09-30 was $679.00K, a 228.02% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for the quarter ending 2019-06-30 was $365.00K.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for the quarter ending 2019-03-31 was $207.00K.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for fiscal 2023 was $1.84M, a 0.22% increase from fiscal 2022.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for fiscal 2022 was $1.84M, a 0.11% increase from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for fiscal 2021 was $1.84M, a 1.87% decline from fiscal 2020.
- ALPINE IMMUNE SCIENCES, INC. operating lease, cost for fiscal 2020 was $1.87M, a 1.73% decline from fiscal 2019.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.84M 10-K · filed 2024-03-20 | |||
| 2022-12-31 | $1.84M 10-K · filed 2024-03-20 | |||
| 2021-12-31 | $1.84M 10-K · filed 2024-03-20 | |||
| 2020-12-31 | $1.87M 10-K · filed 2023-03-23 | |||
| 2019-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.33M derived: sum of 2 quarters · filed 2021-03-18 | $1.70M derived: sum of 3 quarters · filed 2021-03-18 | $1.91M 10-K · filed 2021-03-18 |
| 2019-09-30 | $679.00K 10-Q · filed 2019-11-14 | $1.04M derived: sum of 2 quarters · filed 2019-11-14 | $1.25M 10-Q · filed 2019-11-14 | $1.46M derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | $365.00K 10-Q · filed 2019-08-13 | $572.00K 10-Q · filed 2019-08-13 | $778.00K derived: sum of 3 quarters · filed 2020-03-30 | $985.00K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-03-31 | $207.00K 10-Q · filed 2019-05-09 | $413.00K derived: sum of 2 quarters · filed 2020-03-30 | $620.00K derived: sum of 3 quarters · filed 2020-03-30 | |
| 2018-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $413.00K derived: sum of 2 quarters · filed 2020-03-30 | $811.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $207.00K 10-Q · filed 2019-11-14 | $605.00K 10-Q · filed 2019-11-14 | ||
| 2017-12-31 | $529.00K 10-K · filed 2020-03-30 |